CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease

CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease

Abstract The endocannabinoid CB2 receptor system has been implicated in the neuropathology of Alzheimer’s disease (AD). In order to investigate the impact of the CB2 receptor system on AD pathology, a colony of mice with a deleted CB2 receptor gene, CNR2, was established on a transgenic human mutant...

Full description

Bibliographic Details
Main Authors: Jeremy Koppel, Valerie Vingtdeux, Philippe Marambaud, Cristina d’Abramo, Heidy Jimenez, Mark Stauber, Rachel Friedman, Peter Davies
Format: Article
Language:English
Published: BMC 2013-10-01
Series:Molecular Medicine
Subjects:
Plaque Pathology
Plaque Deposition
Endocannabinoid
Enzymelinked Immunosorbent Assay (ELISA)
Fatty Acid Amide Hydrolase (FAAH)
Online Access:https://doi.org/10.2119/molmed.2013.00140

Internet

https://doi.org/10.2119/molmed.2013.00140

Similar Items